CONGRESS GUIDE

ERS International Congress 2016
DETAILED PROGRAMME
MONDAY 05 SEPTEMBER, 2016
Tag(s) : Translational
Target audience : Allied health professional, Clinician, Lung function technician, Paediatrician, Pharmaceutical industry representative,
Physiologist, Physiotherapist, Pulmonologist, Radiologist, Researcher, Respiratory physician, Respiratory therapist
Chairs : Jane C. Davies (London, United Kingdom)
13:00 Introduction by the chair to the concept of a clinical trials network 2920
13:06
13:14
13:22
13:30
13:50
Ligthning lecture: High resolution CT as a clinical trial outcome measure: standardisation of
performance and scoring
Harm Tiddens (Rotterdam, Netherlands)
Lightning lecture: Lung Clearance Index: why, how, and the lessons learned
Jane C. Davies (London, United Kingdom)
Lightning lecture: Nasal Potential Difference: standardisation process, issues arising and
FDA approvals
Isabelle Sermet-Gaudelus (Paris, France)
Workshop 1: Lung Clearance Index – demonstration of devices utilised by the core facility; best
practices and different approaches to communication with pharmaceutical companies
Katie Bayfield (London, United Kingdom), Clare Saunders (London, United Kingdom)
Workshop 2: Computed tomography – include CT scans and score sheets for delegates to view and
attempt to grade themselves; address any questions regarding specific trials, other grading systems or
other issues delegates have had with CT as an outcome measure
Harm Tiddens (Rotterdam, Netherlands)
2921
2922
2923
2924
2925
14:10
Workshop 3: Nasal Potential Difference (NPD) – demonstration of a video of NPD; discussion of issues
delegates have had with equipment; inform about the NPD standardisation guidelines
Isabelle Sermet-Gaudelus (Paris, France)
Room ICC Capital Suite
10
2926
Session 425 13:00 - 14:00
Registration for this session is additional to the congress registration fee and is €100 on site, €90 standard or €70 for early bird
registration.
Meet the expert: ME5 Persisting symptoms after pulmonary embolism
Aims : Access educational materials here
To describe a diagnostic and therapeutic strategy for patients with persistent symptoms after acute pulmonary embolism (PE); to discuss
the epidemiology of symptoms after acute PE; the differential diagnosis; the pathophysiological mechanisms of disease, including dead
space ventilation, right ventricle dysfunction, and pulmonary hypertension; an overview of how to manage patients with persistent
symptoms; and current treatment strategies including pulmonary endarterectomy (PET) and balloon pulmonary angioplasty (BPA).
Tag(s) : Clinical
Target audience : Cardiologist, Clinician, Junior member, Nurse, Physiotherapist, Pulmonologist, Radiologist, Resident, Respiratory
physician, Trainee
13:00
Persisting symptoms after pulmonary embolism
Matthias Held (Wurzburg, Germany)
Room ICC Capital Suite 6 Session 427 13:00 - 14:00
Registration for this session is additional to the congress registration fee and is €100 on site, €90 standard or €70 for early bird
registration.
Meet the expert: ME6 Dealing with air leaks during noninvasive ventilation
Aims : Access educational materials here
To provide an understanding of the rationale behind using intentional leak circuits in both the acute adult and paediatric setting.
Track(s) : Intensive care
Tag(s) : Clinical
Target audience : Anaesthesiologist, Cardiologist, Emergency medicine doctor, Fellow, Intensivist/critical care physician, Neonatologist,
Nurse, Paediatrician, Pulmonologist, Respiratory therapist, Student
2915
13:00
Dealing with air leaks during NIV
Nicholas S. Hill (Providence, United States of America)
2917
120 26.08.2016